Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherman

Showing results (791-800 of 825) with videos related to

Pageof 83
Sort By:
American Journal of Obstetrics and Gynecology|November 13, 2013
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplementsSusan D Reed, Katherine A Guthrie, Katherine M Newton, et al.
Journal of Digital Imaging|August 16, 2017
Using Natural Language Processing of Free-Text Radiology Reports to Identify Type 1 Modic Endplate ChangesHannu T Huhdanpaa, W Katherine Tan, Sean D Rundell, et al.
Journal of Neurosurgery. Spine|August 20, 2021
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal gliomaOluwaseun O Akinduro, Diogo P Garcia, Dominique M O Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
The New England Journal of Medicine|June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanomaKeith T Flaherty, Caroline Robert, Peter Hersey, et al.
European Radiology|April 20, 2026
Staging of non-metastatic nasopharyngeal carcinoma with PET/CTCaineng Cao, Teeradon Treechairusame, Yingzhi Wu, et al.
Pageof 83

Showing results (791-800 of 825) with videos related to

Sort By:
Pageof 83
American Journal of Obstetrics and Gynecology|November 13, 2013
Menopausal quality of life: RCT of yoga, exercise, and omega-3 supplementsSusan D Reed, Katherine A Guthrie, Katherine M Newton, et al.
Journal of Digital Imaging|August 16, 2017
Using Natural Language Processing of Free-Text Radiology Reports to Identify Type 1 Modic Endplate ChangesHannu T Huhdanpaa, W Katherine Tan, Sean D Rundell, et al.
Journal of Neurosurgery. Spine|August 20, 2021
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal gliomaOluwaseun O Akinduro, Diogo P Garcia, Dominique M O Higgins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2018
Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid CancersLara A Dunn, Eric J Sherman, Shrujal S Baxi, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
International Journal of Radiation Oncology, Biology, Physics|December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck CancerJimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
The New England Journal of Medicine|June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanomaKeith T Flaherty, Caroline Robert, Peter Hersey, et al.
European Radiology|April 20, 2026
Staging of non-metastatic nasopharyngeal carcinoma with PET/CTCaineng Cao, Teeradon Treechairusame, Yingzhi Wu, et al.
Pageof 83